Article
Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals.
Journal of clinical microbiology - 1 Nov 1999
Hubert S K, Mohammed J M, Fridkin S K, Gaynes R P, McGowan J E, Tenover F C
Abstract excerpt
Isolates of Staphylococcus aureus with decreased susceptibilities to glycopeptide antimicrobial agents, such as vancomycin and teicoplanin, have emerged in the United States and elsewhere. Commercially prepared brain heart infusion agar (BHIA) supplemented with 6 microg of vancomycin per ml was shown in a previous study to detect glycopeptide-intermediate S. aureus (GISA) with high sensitivity and specificity;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
